EU cancer estimates for 2020 reveal 2.7 million new cases The European Joint Research Council (JRC) released its 2020 burden of cancer estimates on 22 July, 2020. The report revealed The cancer burden is estimated to have risen to 2.7 million new cases (all types, excluding non-melanoma skin cancer) and 1.3 million deaths in 2020. Female breast cancer remains the most commonly diagnosed. Key findings:
Two new reports find impacts of COVID-19 on clinical trials easing slightly According to findings released by GlobalData Healthcare (9 July, 2020) disruption caused to clinical trials by the COVID-19 pandemic is beginning to ease slightly. After three months of increasing disruptions to trials largely attributed to suspended enrolment there is some evidence of green shoots. Trials that were disrupted due to suspended enrolment are showing signs of recovery
Risk Based Monitoring- a data-centric approach to monitoring The outbreak and spread of the COVID-19 (SARS-CoV-2) pandemic continues to have a significant negative impact on the clinical trials industry. Restrictions to curb the spread of the virus caused many sites to be temporarily closed to external visits and resulted in postponements and delays to trials. In spite of these challenges, the industry has
